baber/WOPTO huggingface dataset:
Patent IE-800964-L (IE)
Title: Adhesive compositions
IPC: C08F279/02
Filed: 1980-05-09
Abstract: A structurally toughened heat resistant adhesive composition comprising a solution of polyisoprene elastomer in polymerizable acrylate ester monomers. The adhesive composition also contains an adhesion promoter, a cross-linking agent, a free-radical generator and a free-radical accelerator. The adhesive compositions are generally used as two-part systems, and yield bonds with improved heat and solvent resistant properties. The polymerizable acrylate ester monomers may be monofunctional or a combination of mono- and polyfunctional monomers. Among the useful classes of monomers are alkyl and cycloalkyl acrylates, alkyl and cycloalkyl methacrylates, alkoxy acrylates and methacrylates, alkylene diacrylates and dimethacrylates. A few of the preferred monomers are methyl methacrylate, lauryl methacrylate, isobornyl methacrylate, and tetrahydrofurfuryl methacrylate. The preferred polyisoprene rubbers are generally copolymers (or block copolymers) of (i) isoprene with styrene, acrylonitrile, or methacrylonitrile; (ii) homopolymers of polyisoprene; or (iii) copolymers of either (i) or (ii) with a functional monomer; or (iv) mixtures of the above. Most preferred are the homopolymers of isoprene.
[EP0040079A1]
Patent IE-800992-L (IE)
Title: Measuring the temperature of hot gases
IPC: G01K1/16
Filed: 1980-05-14
Abstract: The temperature of a hot gas (1) is measured by heat tubes (2, 3) the ends of which project into the gas, and which are maintained at a temperature considerably lower than that of the gas. The heat transferred from the gas to the heat tubes is conducted away, e.g. through rods (8) and (9). From knowledge of the temperature of each heat tube and of the heat flow through the tube, the gas temperature can be computed. The use of the two heat tubes working at different temperatures enables the elimination from the computation of some uncertain parameters. 
[EP0019480A2]
Patent FI-813015-L (FI)
Inventor: GUPTA ACHINTYA KUMAR SEN
IPC: C11B7/00
Filed: 1981-09-28
Abstract: The invention provides a process for fractionation of compounds which in essentially non-polar solvents form mixed or co-micelles and hence cannot normally be fractionated by membrane filtration. By dissolving a mixture of such compounds in a solvent system in which selective micelles formation occurs, and contacting the solution under pressure with a semipermeable membrane to separate the mixture into a permeate and a retentate, fractionation of the compound mixture can be achieved, i.e. a fraction enriched in one of said compounds can be recovered from the permeate and/or the retentate by removing solvent therefrom. The new process is in particular useful for fractionating phosphatides-containing mixtures into a fraction enriched in phosphatidyl choline by ultrafiltration of a solution of the mixture in a solvent system comprising an essentially non-polar solvent and a polar solvent, e.g. hexane-ethanol, etc., through a semipermeable membrane, and recovering a fraction enriched in phosphatidyl choline from the permeate. A fraction enriched in phosphatidyl inositol can be recovered from the retentate.
Patent IE-44956-L (IE)
Title: Pneumatic tyre.
IPC: B60C9/28
Filed: 1977-05-17
Abstract: A vehicle tire combining improved riding comfort, road gripping characteristics and tire tread wear has the conventional radial carcass and tread and an improved annular breaker structure reinforcing the crown portion of the tire. The improved breaker structure has two or more layers of metallic cords disposed at an angle of about 10 DEG to about 35 DEG with the longitudinal direction of the tire. The metallic cords of one layer cross those of the adjacent layer. At least one layer of nylon or similar textile cords which shrink when the tire is heat cured is disposed between the radially outermost layer of metallic cords and the tread. The textile cords are disposed around the circumference of the tire in planes which are substantially parallel to the longitudinal direction of the tire and at densitities along the lateral edges of the breaker which are at least about 50% higher than the density thereof in the crown zone of the breaker.
[US4140168A]
Patent IE-881073-L (IE)
Title: Novel solid, nondigestible, fat-like compounds.
IPC: C07H13/06
Filed: 1988-04-08
Abstract: Fatty acid esters of sucrose wherein the fatty acid groups consist essentially of short chain fatty acid radicals containing from 2 to 10 carbon atoms and long chain fatty acid radicals containing from 20 to 24 carbon atoms in a molar ratio of short chain:long chain radicals of 5:3 to 3:5, the said esters having a degree of esterification of about 7 to 8. The compounds are useful as nondigestible substitutes for solid fats in foods.
Patent IE-45445-L (IE)
Title: New antibiotic.
IPC: A61K35/66
Filed: 1977-06-28
Abstract: The invention relates to a new antibiotic and a process of its preparation. [FR2356666A1]
Patent IE-43198-L (IE)
Title: Prostanoic acid derivatives
IPC: C07C35/06
Filed: 1975-07-11
Abstract: 1486832 Compositions containing prostaglandins IMPERIAL CHEMICAL INDUSTRIES Ltd 7 July 1975 [5 Aug 1974] 34334/74 Heading A5B [Also in Divisions C2 and C3] Pharmaceutically and veterinary compositions in a form suitable for oral, parenteral, rectal, vaginal administration or for inhalation, contain prostaglandins of the formula I wherein either R' is carboxy hydroxymethyl or (C 1-10 alkoxy) carbonyl, R<SP>4</SP> is OH and R<SP>5</SP> is H 1 or R<SP>1</SP> is carboxy or (C 1-10 alkoxy) carbonyl and R<SP>4</SP> and R<SP>5</SP> together form an oxo radical; R<SP>2</SP> is OH or C 1-4 alkoxy; Y is ethylene or trans-vinylene, either A is ethylene or vinylene and X is C 1-6 alkylidene-oxy wherein the alkylidene is bonded to CHR and the oxygen is bonded to R<SP>3</SP>, or C 1-6 alkylidene, or A is vinylene and X is a direct bond; and R<SP>3</SP> is phenyl or naphthyl optionally substituted by one or two halogen atoms, NO2, OH, CF 3 , phenyl, C 1-5 alkyl, di(C 1-5 alkyl) amino, C 2-5 alkenyl or C 1-5 alkoxy radicals, or for these compounds wherein R' is carboxy the pharmaceutically or veterinary acceptable salts thereof together with pharmaceutically or veterinarily acceptable diluents or carriers. The compounds may be used in combination, or concurrently with uterine stimulants, for example, oxytosin, or gonadotrophins, for example pregnant mare serum gonadotrophin or human chorionic gonadotrophin. The compounds are used in the induction of labour, the control of the oestrus cycle, as contraceptives, as hypotensives, for the relief of bronchospasm, or as inhibitors of gastric secretion or blood platelet aggregation.
[GB1486832A]
Patent IE-801951-L (IE)
Title: Power supply bus bar
IPC: H04Q1/02
Filed: 1980-09-18
Abstract: 1. A bar (15) for the distribution of electrical energy in an equipment frame (14), comprising an insulating cover which is cut up into pieces and which is situated in a container, and comprising electrical conductor rods (6, 6A) which are disposed inside the cover in such a way that they are electrically insulated one from the others and that their connection strips (7, 7A) which are also insulated one from the others are allowed to project out of the container in only one plane which is parallel to the rods, said bar being characterized in that it comprises a container which is constituted by two metal bands (1, 2), these bands being welded together along one of their large sides and over a certain width and being distanced from one another over the remaining width in order to constitute a protection sheath, that the electrical conductor rods (6, 6A) are inserted into longitudinal slots (5, 5A) which are provided in opposite surfaces of two plastics sections (4, 4A) constituting the insulating cover and disposed between the metal bands in their distanced area, and that an insulating member (8 or 8A) which is provided with windows (9) opposite to the connection area between the rods (6 or 6A) and their respective connection strips (7 or 7A), is inserted between the connection strips (7 or 7A) of the rods (6 or 6A) situated in a plastics section (4 or 4A) and that section.
[EP0025947A1]
Patent IE-882710-L (IE)
Title: Cycloalkanols
IPC: C07D241/20
Filed: 1988-09-07
Abstract: Compounds of the formula: <CHEM> in which m is one of the integers 1,2 or 3; n is one of the integers 0,1 or 2; o is one of the integers 0,1 or 2; R1 and R2 are, independently, hydrogen, hydroxyl, alkyl, alkoxy, alkanoyloxy, trifluoromethyl, halo, or, when taken together, 3,4-methylenedioxy; R3 is alkyl, <CHEM> where R4 and R5 are, independently, hydrogen, hydroxy;l, alkyl, alkoxy, alkanoyloxy, halo or trifluoromethyl; and R6 is hydrogen or halo; or a pharmaceutically acceptable salt thereof, are useful in treatment of psychiatric disorders.
Patent IE-893318-L (IE)
Title: New amino-chromanol derivatives, process for the preparation¹thereof and pharmaceutical compositions containing them
IPC: C07D405/04
Filed: 1989-10-16
Abstract: New aminochromanol compounds of the formula: (I) in which X is cyano, nitro, trifluoromethyl, alkoxycarbonyl, carbamido, dialkylcarbamido, aminosulfonyl, dialkylaminosulfonyl, alkylsulfonyl, alkylsulfonylamino or acyl; CH2-R is attached (in the 5 position of the pyrrolidinone nucleus) to an R- or S-configured carbon atom, and R is: either OR' or SR' in which R' is hydrogen, (C1-C10)-alkyl, (C1-C5-alkyl)-carbonyl or and physiologically tolerable acid addition salts thereof, in the case where R contains a basic function. These compounds and their physiologically tolerable salts can be used in therapeutics for the activation of potassium channels, especially in the treatment of disorders associated with abnormal smooth muscle contraction and in the cardiovascular, bronchopulmonary, digestive, urinary and uterine fields.
Patent NO-822568-L (NO)
Inventor: CHAPLEO CHRISTOPHER BOURNE
IPC: C07D405/04
Filed: 1982-07-26
Abstract: Imidazoline derivatives of the formula   <IMAGE> (I)  wherein R1 is hydrogen or alkyl C1-6; R2 is hydrogen, methyl, chloro, bromo or fluoro; R3 is hydrogen, methyl, hydroxy, methoxy, fluoro, chloro or bromo; and their non-toxic salts. Processes for their preparation and pharmaceutical compositions thereof. The compounds exhibit presynaptic  alpha 2-adrenoreceptor antagonist activity.
Patent NO-842760-L (NO)
Inventor: WEBSTER GEORGE ANDREW
IPC: C23F13/02
Filed: 1984-07-06
Abstract: A pipe having an elastomeric coating bonded to it and a sacrificial anode embedded in the coating and spaced from the pipe by the elastomer, the anode being in electrical contact with the pipe and being substantially flush with the outer wall of the coating to provide cathodic protection of thin-coated pipes without interfering with their passage of rollers on reel lay barges and the like.
Patent NO-860866-L (NO)
Inventor: SCHATZ HERMANN
IPC: C08G14/06
Filed: 1986-03-07
Abstract: A cold-stable, aqueous adhesive resin solution of products of the condensation of formaldehyde with a combination of phenol, urea and melamine components is obtainable by condensation of the phenol, urea and melamine components with formaldehyde in the presence of at least 0.5% by weight of  epsilon -aminocaprolactam or  epsilon -aminocaproic acid, based on the total weight of the adhesive resin solution.
Patent NO-861851-L (NO)
Title: Fremgangsmaate for bestemmelse av ondartede svulster.
Inventor: AURAS-BLANK HANNELORE
IPC: G01N33/50
Filed: 1986-05-09
Abstract: Det beskrives en fremgangsmåte for påvisning av ondartede svulster i en blodprøve fra et menneske eller et pattedyr som i det vesentlige består deri at det fremstilles et blodutstryk som er vesentlig tykkere enn vanlig og ved tørking i 10 til 30 minutter i luft over-føres til en bestemt konsistens som muliggjør erkjennelse av oppløs-ningsgraden av blod som er betinget av ondartede svulster.
Patent NO-863071-L (NO)
Inventor: HELLSTROEM INGEGERD
IPC: C07K16/30
Filed: 1986-07-29
Abstract: The present invention is concerned with novel monoclonal antibodies which define a glycolipid antigen associated with human non-small cell lung carcinomas ("NSCLC") and certain other human carcinomas. The antibodies bind to normal human cells to a much lesser degree than to tumor cells. The antibodies find use in diagnostic methods such as the detection of malignant cells associated with NSCLC and in therapeutic methods. Also disclosed in a novel glycolipid antigen. The invention also comprises a method for determining the presence of a malignant condition in lung tissue and other human tissue. The method involves examining the human tissue for the presence of a glycolipid antigen having the terminal carbohydrate sequence: GalNAc beta l->4Gal beta l->3GalNAc beta l->4Gal beta l->R.
Patent NO-870573-L (NO)
Inventor: SCHEFFEL GARY WILLIAM
IPC: F16K1/36
Filed: 1987-02-13
Abstract: A valve member (E) for a shut-off valve has a stem tip seal (F) and is adapted for selective movement axially towards and away from an associated valve seat (76). A generally cylindrical sleeve (80) is carried by the valve member (E) and has an end defining an outer annular seal surface (91) adapted for cooperative sealing engagement with the seat (76). Mounted centrally within the sleeve (80) for limited axial movement is a rigid cylindrical body (88) that defines an inner annular seal surface (90) adapted for engagement with the seat (76) at a location radially inwardly of the outer annular seal surface. Formed between the sleeve (80) and the rigid body (88) is an annular chamber (96) which opens axially inwardly from a narrow slot (94) located between the inner annular seal surface (90) and the outer annular seal surface (91). A mass of resilient packing material (97) substantially fills the chamber (96) and extends axially outwardly of the slot (94) to define a medial annular seal surface (103). Means are associated with the rigid body (88) for generating pressure on the packing material (97) when the body is forced axially towards the valve member (E). In addition, the inner annular seal surface (90) is configured to engage the seat (76) prior to engagement by either the medial annular seal surface (103) or the outer annular seal surface (91).
Patent NO-870844-L (NO)
Inventor: LACOMBE JEAN-LOUP
IPC: C08F4/02
Filed: 1987-03-02
Abstract: Spherical catalyst support manufactured by reaction of an organic chlorine compound in the presence of an electron donor and of a mixture of an alkylmagnesium compound and of an organic aluminium compound, characterised in that the organic chlorine compound, in combination with an electron donor, is reacted with the preliminary mixture of alkylmagnesium compound, aluminoxane and/or aluminosiloxane and optionally of electron donor. This support, subjected to a second activation with a chlorine compound, is impregnated with a transition metal halide.
Patent NO-892266-L (NO)
Inventor: BONIN WERNER
IPC: A61P7/02
Filed: 1989-06-02
Abstract: The invention relates to a new active substance-amblyommin-for anticoagulant therapy and to a process for the isolation thereof from hard ticks. The isolated protein having a thrombin-inhibitory action has a molecular weight of 20000 to 30000 dalton, an isoelectric point between 5.05 and 5.65 and the partial amino acid sequences Ile-Leu-Phe-Thr-Gln-Gly-Asn-X-Gly-Glu-Leu-Glu-Asn-X-Phe-Glu-, Lys-Ile-Leu-Phe-X-Gln-Gly- and Ala-Ser-Tyr-Ile-Val-X-Ser-Glu-Ser-Ile-Gln-Ile-Leu-X-Leu-Ser-Glu-Gly-Ile- in which each radical X can be identical or different and each represents a naturally occurring amino acid.
Patent NO-910075-L (NO)
Title: Lipidselektive antioksydanter samt deres fremstilling og anvendelse.
Inventor: WEITHMANN KLAUS-ULRICH
IPC: C07D319/06
Filed: 1991-01-08
Abstract: Det er beskrevet llpldselektlve antioksydanter med generell formel I (A)a(L)(X)a. (I). hvor a og a' uavhengig av hverandre er tallene l eller 2; A er en aktloksydatlv komponent som, bl.a. kan utgjøres av en kromandelstruktur av vitamin E CHJ CHj CHJ hvor O l denne og alle følgende formler utgjør en fri kovalent enkel tblndlngs-valens, eller en alkylsubstltuert mono-, dl- eller trlfenolrest (OH)m hvor m - l eller 2, n - l eller 2, og m+n - 3 eller 4, R1 - alkylrest og/eller alkoksyrest og det samlede antallet C-atomer av alkyl- hhv. alkoksyresten hhv. alkyl- og alkoksyrestene - maksimalt 8; L er et broledd bestående av en eller flere av byggestenene R10 O OR10 O l II l ,. II -C- -C- -C- , -O-, -S-, -NR10- og -P- Rli R12 R12 hvor R10, R11, R12 kan være H, lavere alkylrest (fortrinnsvis Ci-C4) eller O, X er en llpofll komponent valgt fra gruppen kolanderlvatrester og alkyl- eller cykloalkylrester eller fett- syrederlvatrester med Inntil 24 C-atomer. Forbindelsene anvendes for beskyttelse av llpldholdlge stoffer mot oksydasjon samt l legemidler for profylakse og terapi av sykdommer hvorved bloradlkaler er Involvert, spesielt l hjerte-kretsløp- og kursykdoniner .
Patent NO-922437-L (NO)
Title: Terapeutisk aktive fluorsubstituerte benzimidazoler, fremgangsmaate for deres fremstilling samt deres anvendelse
Inventor: BRAENDSTROEM ARNE
IPC: C07D401/12
Filed: 1992-06-19
Abstract: Nye forbindelser med formelen: (D hvor F er i 5- eller 6-stilllng, og OCH hvor i begge formler R er gruppen -CE20COOR1, hvor R1 er en rett eller forgrenet alkyl inneholdene 1-6 karbonatomer eller benzyl, eller R! er gruppen -(CH2)n-CON N-CH3, -(CH2)n-COOH eller -(CH2)n-S03H hvor n er 1-6 samt fysiologisk akseptable salter, samt mellomprodukter, farmasøytiske preparater inneholdene slike forbindelser som aktiv bestanddel, og anvendelsen av forbindelsene i medisinen.
Patent NO-933759-L (NO)
Inventor: HITTINGER CHRISTEL
IPC: C08G12/12
Filed: 1993-10-19
Abstract: Aqueous urea-formaldehyde resins obtainable by condensation of urea and formaldehyde in an acidic medium in the presence of di- or polycarboxylic acids. The resins are suitable as binders in the production of mouldings from lignocellulose-containing materials.
Patent NO-934765-L (NO)
Title: Anordning ved renseanlegg
Inventor: OWESEN YNGVAR S
IPC: A61L9/16
Filed: 1993-12-22
Abstract: Den foreliggende oppfinnelse vedrører en anordning ved renseanlegg/ spesielt for rensing av mikropar- tikler og mikroorganismer, og i den hensikt å fremskaffe et filter med betydelig bedre kapasitet både hva angår oppsamling av partikler, samt uskadeliggjøring av sopp, bakterier og virus, er det ifølge oppfinnelsen foreslått at anordningen (1; 101) omfatter et husorgan (2; 102) som rommer forfilter (3; 103), UV-strålekilder (4n; 104n), vifte (5; 105) og etterfilter (6; 106), for rensing og bestråling av romluft.
Patent NO-962016-L (NO)
Inventor: DOMAGALA JOHN MICHAEL
IPC: C07D407/04
Filed: 1996-05-15
Abstract: The present invention relates to novel tri- and tetrasubstituted pyrones and related structures which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The pyrone derivatives are useful in the development of therapies for the treatment of bacterial and viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of multifunctionalized pyrones and of related structures.
Patent NO-972481-L (NO)
Title: Fremgangsmåte ved fremstilling av sildenafil
Inventor: DUNN PETER JAMES
IPC: C07D295/22
Filed: 1997-05-30
Abstract: Det beskrives en fremgangsmåte ved fremstilling av en forbindelse med formel (I):hvilken fremgangsmåte omfatter syklisasjon av en forbindelse med formel (II):
Patent NO-973391-L (NO)
Inventor: KING JOHN FREDERICK
IPC: C22C23/06
Filed: 1997-07-23
Abstract: A magnesium base alloy for high pressure die casting (HPDC), providing good creep and corrosion resistance, comprises: at least 91 weight percent magnesium; 0.1 to 2 weight percent of zinc; 2.1 to 5 percent of a rare earth metal component; 0 to 1 weight percent calcium; 0 to 0.1 weight percent of an oxidation inhibiting element other than calcium (e.g., Be); 0 to 0.4 weight percent zirconium, hafnium and/or titanium; 0 to 0.5 weight percent manganese; no more than 0.001 weight percent strontium; no more than 0.05 weight percent silver and no more than 0.1 weight percent aluminum; any remainder being incidental impurities. For making prototypes, gravity (e.g. sand) cast and HPDC components from the alloy have similar mechanical properties, in particular tensile strength. The temperature dependence of the latter, although negative, is much less so than for some other known alloys.
Patent NO-980567-L (NO)
Inventor: LOFTUS STEPHEN CLIVE
IPC: B65D21/06
Filed: 1998-02-10
Abstract: A container (10) is formed to allow a second like container to nest therein when the two containers are in a first relative orientation, and to stack thereon when the two containers are in a second relative orientation. Stacking means shown generally at (12) have a stowed position (to the left in the drawing) in which stacking or nesting as aforesaid are possible, and a stacking position (to the right of the drawing) in which the stacking means (12) interfere with nesting to cause the containers to stack when in the second relative orientation.
Patent NO-982266-L (NO)
Inventor: CAULEY THOMAS
IPC: D21H17/37
Filed: 1998-05-18
Abstract: Filled paper is made by adding a cationising amount of cationic polymer to precipitated calcium carbonate or other filler either as a slurry or in a thick stock component, producing a thin stock containing the cationised filler and then treating the thin stock with a formaldehyde resin and polyethylene oxide as a retention system prior to drainage and drying.
Patent SE-0001201-L (SE)
Inventor: HALL JAN
IPC: A61L27/32
Filed: 2000-04-04
Abstract: An implant (1) has attachment and hole-insert parts (2, 3) with an outer surface or outer surfaces having external layer arrangements (6, 7). The implant can be provided in a known manner with threads (3a, 3b) on cylindrical and conical portions. The implant is made in principle in two production stages. In a first production stage, the outer surface or outer surfaces (6a) of the implant are given a relatively high roughness value and/or a relatively high degree of porosity. In a second stage, the uneven or porous surface thus obtained is coated with an oxide layer (7) which can be uniform or can have different thicknesses along the longitudinal and/or circumferential directions(s) of the implant. In one embodiment, the oxide layer (7) can be coated with a bone-growth agent or bone-growth-promoting agent and/or calcium phosphate (16), for example by means of chemical deposition, dipping or sputtering.